Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (1-10 of 247) with videos related to

Pageof 25
Sort By:
Future Cardiology|October 7, 2009
Bosentan for pulmonary hypertension and other pulmonary diseases: emerging evidenceRobert P Frantz
Current Opinion in Pulmonary Medicine|July 18, 2023
Group 2 pulmonary hypertension: from diagnosis to treatmentRobert P Frantz
Circulation|October 30, 2015
Whither Anticoagulation in Pulmonary Arterial Hypertension? Conflicting Evidence REVEALedRobert P Frantz
Chest|April 8, 2020
Rebuttal From Dr FrantzRobert P Frantz
Pulmonary Circulation|April 17, 2025
Editorial on "Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center"Robert P Frantz
The Lancet. Respiratory Medicine|March 27, 2021
REPLACE and the role of riociguat in pulmonary arterial hypertension therapyRobert P Frantz
The European Respiratory Journal|August 2, 2015
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigmRobert P Frantz
JACC. Asia|January 30, 2023
Vascular Injury During Balloon Pulmonary Angioplasty: Prepare for the RareRobert P Frantz
JACC. Advances|June 28, 2024
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Here to Stay, More to LearnRobert P Frantz
Postgraduate Medicine|September 27, 2000
Beta blockade in patients with congestive heart failure. Why, who, and howR P Frantz
Pageof 25

Showing results (1-10 of 247) with videos related to

Sort By:
Pageof 25
Future Cardiology|October 7, 2009
Bosentan for pulmonary hypertension and other pulmonary diseases: emerging evidenceRobert P Frantz
Current Opinion in Pulmonary Medicine|July 18, 2023
Group 2 pulmonary hypertension: from diagnosis to treatmentRobert P Frantz
Circulation|October 30, 2015
Whither Anticoagulation in Pulmonary Arterial Hypertension? Conflicting Evidence REVEALedRobert P Frantz
Chest|April 8, 2020
Rebuttal From Dr FrantzRobert P Frantz
Pulmonary Circulation|April 17, 2025
Editorial on "Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center"Robert P Frantz
The Lancet. Respiratory Medicine|March 27, 2021
REPLACE and the role of riociguat in pulmonary arterial hypertension therapyRobert P Frantz
The European Respiratory Journal|August 2, 2015
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigmRobert P Frantz
JACC. Asia|January 30, 2023
Vascular Injury During Balloon Pulmonary Angioplasty: Prepare for the RareRobert P Frantz
JACC. Advances|June 28, 2024
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Here to Stay, More to LearnRobert P Frantz
Postgraduate Medicine|September 27, 2000
Beta blockade in patients with congestive heart failure. Why, who, and howR P Frantz
Pageof 25